Calliditas: First patient enrolled in Phase III

Research Note

2018-11-13

17:01

The first patient has been enrolled in the Phase III NEFIGARD study, putting the company on-track to reach its goal of top-line readout in H2-2020.

MS

Mathias Spinnars

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.